HB 477 would create new provisions in Kentucky law protecting access to assisted reproductive technology (ART), including treatments and procedures involving human eggs or embryos such as in vitro fertilization, gamete intrafallopian transfer, and zygote intrafallopian transfer. It defines a covered “health care provider” as a licensed facility or individual involved in delivering ART-related services, counseling, referrals, or fertility-related items and services.
The bill prohibits the Commonwealth and its political subdivisions from prohibiting, unreasonably limiting, or interfering with an individual’s access to ART or a provider’s ability to perform or assist with ART procedures. At the same time, it preserves the state’s ability to enforce health and safety regulations governing health care facilities and providers. The bill also adds a separate provision stating that a fertilized human egg or embryo outside the uterus is not to be treated as an unborn child, minor child, natural person, or similar legal term under state law.
Impact
HB 477 would affect Kentucky statutes by adding new protections in KRS Chapter 216 and KRS Chapter 311 for fertility treatment access and by clarifying the legal status of embryos outside the uterus. In practical terms, it would limit state and local government actions that could restrict IVF and related reproductive services, while leaving ordinary health and safety oversight intact. It could also influence how embryos are treated in other areas of state law by expressly excluding them from personhood-type definitions when outside the human body.
Sentiment
Based on the bill text and the absence of recorded committee debate or votes in the provided materials, the bill appears to be framed as a protective access measure for fertility care rather than a punitive or regulatory restriction. Its language suggests a pro-access, pro-reproductive-health orientation, with an emphasis on preserving patient and provider rights. No formal voting history or transcript evidence is available here to indicate broader legislative support or opposition.
Contention
The main point of contention is likely the bill’s embryo-status provision, which states that an embryo outside the uterus is not an unborn child, minor child, natural person, or similar term under state law. Supporters would likely view this as necessary to protect IVF and related fertility treatments from legal uncertainty, while opponents may object on moral, religious, or fetal-personhood grounds. Another possible area of dispute is the breadth of the prohibition on government interference with ART access, though the bill expressly preserves health and safety regulation.